Furthermore, we examined the mechanisms by which ADAM17/EGFR/MAPK/ERK pathway contributed to miR-145-induced inhibition on glioma proliferation, invasion, and angiogenesis after transfection of miR-145. Here, ADAM17 is linked to glioma.